• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在接受酶替代疗法治疗12年的一名Hurler-Scheie综合征女性患者的中枢神经系统中P- tau蛋白和线粒体ATP合酶亚基c的积累

P-Tau and Subunit c Mitochondrial ATP Synthase Accumulation in the Central Nervous System of a Woman with Hurler-Scheie Syndrome Treated with Enzyme Replacement Therapy for 12 Years.

作者信息

Kobayashi Hiroshi, Ariga Masamichi, Sato Yohei, Fujiwara Masako, Fukasawa Nei, Fukuda Takahiro, Takahashi Hiroyuki, Ikegami Masahiro, Kosuga Motomichi, Okuyama Torayuki, Eto Yoshikatsu, Ida Hiroyuki

机构信息

Division of Gene Therapy, Research Center of Medical Sciences, Jikei University School of Medicine, Tokyo, Japan.

Department of Pediatrics, Jikei University School of Medicine, Tokyo, Japan.

出版信息

JIMD Rep. 2018;41:101-107. doi: 10.1007/8904_2018_106. Epub 2018 Apr 29.

DOI:10.1007/8904_2018_106
PMID:29705972
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6122043/
Abstract

We report an autopsy case of a woman with mucopolysaccharidosis type I (MPS I) Hurler-Scheie syndrome who was treated with enzyme replacement therapy (ERT) for 12 years. This was the first case of MPS I treated with ERT in Japan. Pathological analysis showed no glycosaminoglycan accumulation in the liver and spleen as a result of long-term ERT, although severe aortic stenosis, diffuse intimal hyperplasia of the coronary artery, and fibrous hypertrophy of the endocardium were observed. Additionally, we detected subunit c mitochondrial ATP synthase (SCMAS) accumulation and mild tauopathy (hyperphosphorylated tau or p-tau, both 3-repeat and 4-repeat tau accumulation) in the same area of the cerebral limbic system and central gray matter of the mid brain and pons. Tauopathy is an important pathological finding in Alzheimer's disease and other neurodegenerative disorders; however, in MPS I, it is unclear whether tauopathy is a primary or secondary phenomenon. Thus, in this report, we describe pathological accumulation of p-tau and SCMAS in the context of MPS I and discuss the mechanisms and importance of these findings in the pathogenesis of MPS I.

摘要

我们报告了一例黏多糖贮积症I型(MPS I)Hurler-Scheie综合征女性患者的尸检病例,该患者接受了12年的酶替代疗法(ERT)。这是日本首例接受ERT治疗的MPS I病例。病理分析显示,长期ERT治疗后肝脏和脾脏未出现糖胺聚糖蓄积,尽管观察到严重的主动脉瓣狭窄、冠状动脉弥漫性内膜增生以及心内膜纤维性肥厚。此外,我们在大脑边缘系统以及中脑和脑桥的中央灰质的同一区域检测到亚基c线粒体ATP合酶(SCMAS)蓄积和轻度tau蛋白病(过度磷酸化tau或p-tau,3重复和4重复tau均蓄积)。Tau蛋白病是阿尔茨海默病和其他神经退行性疾病的重要病理表现;然而,在MPS I中,尚不清楚tau蛋白病是原发性还是继发性现象。因此,在本报告中,我们描述了MPS I背景下p-tau和SCMAS的病理蓄积,并讨论了这些发现在MPS I发病机制中的机制和重要性。

相似文献

1
P-Tau and Subunit c Mitochondrial ATP Synthase Accumulation in the Central Nervous System of a Woman with Hurler-Scheie Syndrome Treated with Enzyme Replacement Therapy for 12 Years.在接受酶替代疗法治疗12年的一名Hurler-Scheie综合征女性患者的中枢神经系统中P- tau蛋白和线粒体ATP合酶亚基c的积累
JIMD Rep. 2018;41:101-107. doi: 10.1007/8904_2018_106. Epub 2018 Apr 29.
2
Residual glycosaminoglycan accumulation in mitral and aortic valves of a patient with attenuated MPS I (Scheie syndrome) after 6 years of enzyme replacement therapy: Implications for early diagnosis and therapy.酶替代治疗6年后,1例MPS I(谢伊综合征)症状较轻患者二尖瓣和主动脉瓣中残留糖胺聚糖的蓄积:对早期诊断和治疗的启示
Mol Genet Metab Rep. 2015 Nov 8;5:94-97. doi: 10.1016/j.ymgmr.2015.10.014. eCollection 2015 Dec.
3
Medium-term outcome of transcatheter aortic valve replacement in mucopolysaccharidosis type I-HS (Hurler-Scheie syndrome).I型黏多糖贮积症-HS型(Hurler-Scheie综合征)经导管主动脉瓣置换术的中期结果
J Cardiol Cases. 2023 Jan 7;27(4):196-198. doi: 10.1016/j.jccase.2022.12.015. eCollection 2023 Apr.
4
Mucopolysaccharidosis type I.I型黏多糖贮积症
Pediatr Endocrinol Rev. 2014 Sep;12 Suppl 1:102-6.
5
Progressive eye pathology in mucopolysaccharidosis type I mice and effects of enzyme replacement therapy.黏多糖贮积症Ⅰ型小鼠的进行性眼部病变及酶替代治疗的效果。
Clin Exp Ophthalmol. 2020 Apr;48(3):334-342. doi: 10.1111/ceo.13713. Epub 2020 Jan 30.
6
Long-term cognitive and somatic outcomes of enzyme replacement therapy in untransplanted Hurler syndrome.未经移植的Hurler综合征患者接受酶替代疗法的长期认知和躯体结局
Mol Genet Metab Rep. 2017 Sep 27;13:64-68. doi: 10.1016/j.ymgmr.2017.07.012. eCollection 2017 Dec.
7
Enzyme replacement therapy with laronidase (Aldurazyme(®)) for treating mucopolysaccharidosis type I.用拉罗尼酶(阿糖苷酶α(Aldurazyme(®)))进行酶替代疗法治疗I型黏多糖贮积症。
Cochrane Database Syst Rev. 2016 Apr 1;4:CD009354. doi: 10.1002/14651858.CD009354.pub4.
8
Enzyme replacement therapy with laronidase (Aldurazyme(®)) for treating mucopolysaccharidosis type I.用拉罗尼酶(阿糖苷酶α(商品名:Aldurazyme(®)))进行酶替代疗法治疗I型黏多糖贮积症。
Cochrane Database Syst Rev. 2013 Nov 21(11):CD009354. doi: 10.1002/14651858.CD009354.pub3.
9
Enzyme replacement therapy with laronidase (Aldurazyme) for treating mucopolysaccharidosis type I.用拉罗尼酶(阿糖苷酶α)进行酶替代疗法治疗I型黏多糖贮积症。
Cochrane Database Syst Rev. 2013 Sep 26(9):CD009354. doi: 10.1002/14651858.CD009354.pub2.
10
Enzyme replacement therapy with laronidase (Aldurazyme) for treating mucopolysaccharidosis type I.用拉罗尼酶(阿杜糖酶)进行酶替代疗法治疗I型黏多糖贮积症。
Cochrane Database Syst Rev. 2019 Jun 18;6(6):CD009354. doi: 10.1002/14651858.CD009354.pub5.

引用本文的文献

1
The Inflammation in the Cytopathology of Patients With Mucopolysaccharidoses- Immunomodulatory Drugs as an Approach to Therapy.黏多糖贮积症患者细胞病理学中的炎症——以免疫调节药物作为治疗方法
Front Pharmacol. 2022 May 13;13:863667. doi: 10.3389/fphar.2022.863667. eCollection 2022.
2
Pathogenesis of Mucopolysaccharidoses, an Update.黏多糖贮积症的发病机制:更新。
Int J Mol Sci. 2020 Apr 4;21(7):2515. doi: 10.3390/ijms21072515.
3
Novel Enzyme Replacement Therapies for Neuropathic Mucopolysaccharidoses.新型酶替代疗法治疗神经病变黏多糖贮积症。
Int J Mol Sci. 2020 Jan 8;21(2):400. doi: 10.3390/ijms21020400.
4
Recent trends in mucopolysaccharidosis research.黏多糖贮积症研究的最新趋势。
J Hum Genet. 2019 Feb;64(2):127-137. doi: 10.1038/s10038-018-0534-8. Epub 2018 Nov 19.

本文引用的文献

1
Macrophage enzyme and reduced inflammation drive brain correction of mucopolysaccharidosis IIIB by stem cell gene therapy.巨噬细胞酶和炎症减轻驱动干细胞基因疗法纠正黏多糖贮积症 IIIB 型的脑病变。
Brain. 2018 Jan 1;141(1):99-116. doi: 10.1093/brain/awx311.
2
Angiotensin receptor blockade mediated amelioration of mucopolysaccharidosis type I cardiac and craniofacial pathology.血管紧张素受体阻断介导的对I型黏多糖贮积症心脏和颅面病理的改善作用。
J Inherit Metab Dis. 2017 Mar;40(2):281-289. doi: 10.1007/s10545-016-9988-z. Epub 2016 Oct 14.
3
Report of 5 novel mutations of the α-L-iduronidase gene and comparison of Korean mutations in relation with those of Japan or China in patients with mucopolysaccharidosis I.黏多糖贮积症 I 型患者中 α-L-艾杜糖醛酸酶基因 5 种新突变的报告及韩国突变与日本和中国突变的比较。
BMC Med Genet. 2016 Aug 12;17(1):58. doi: 10.1186/s12881-016-0319-x.
4
Dataset and standard operating procedure for newborn screening of six lysosomal storage diseases: By tandem mass spectrometry.六种溶酶体贮积症新生儿筛查的数据集及标准操作程序:采用串联质谱法
Data Brief. 2016 Jul 5;8:915-24. doi: 10.1016/j.dib.2016.06.052. eCollection 2016 Sep.
5
Hematopoietic stem cell transplantation for inborn errors of metabolism: A report from the Research Committee on Transplantation for Inborn Errors of Metabolism of the Japanese Ministry of Health, Labour and Welfare and the Working Group of the Japan Society for Hematopoietic Cell Transplantation.用于先天性代谢缺陷的造血干细胞移植:日本厚生劳动省先天性代谢缺陷移植研究委员会及日本造血细胞移植学会工作组的报告。
Pediatr Transplant. 2016 Mar;20(2):203-14. doi: 10.1111/petr.12672. Epub 2016 Jan 25.
6
Effects of enzyme replacement therapy started late in a murine model of mucopolysaccharidosis type I.在I型黏多糖贮积症小鼠模型中晚期开始的酶替代疗法的效果。
PLoS One. 2015 Feb 3;10(2):e0117271. doi: 10.1371/journal.pone.0117271. eCollection 2015.
7
Delivery of an enzyme-IGFII fusion protein to the mouse brain is therapeutic for mucopolysaccharidosis type IIIB.将一种酶-IGFII融合蛋白递送至小鼠大脑对IIIB型黏多糖贮积症具有治疗作用。
Proc Natl Acad Sci U S A. 2014 Oct 14;111(41):14870-5. doi: 10.1073/pnas.1416660111. Epub 2014 Sep 29.
8
Tau pathology induces intraneuronal cholesterol accumulation.tau蛋白病变会导致神经元内胆固醇积聚。
J Neuropathol Exp Neurol. 2014 Sep;73(9):846-54. doi: 10.1097/NEN.0000000000000103.
9
High-dose enzyme replacement therapy in murine Hurler syndrome.高剂量酶替代疗法治疗鼠类黏多糖贮积症Ⅰ型。
Mol Genet Metab. 2014 Feb;111(2):116-22. doi: 10.1016/j.ymgme.2013.09.008. Epub 2013 Sep 19.
10
Improvement of CNS defects via continuous intrathecal enzyme replacement by osmotic pump in mucopolysaccharidosis type II mice.通过鞘内持续酶替代疗法和渗透泵治疗黏多糖贮积症Ⅱ型小鼠的中枢神经系统缺陷。
Am J Med Genet A. 2013 May;161A(5):1036-43. doi: 10.1002/ajmg.a.35869. Epub 2013 Mar 25.